H-RRRFRPASPLRGPPK-OH

Ref. 3D-PP48268

Informations sur le produit

• Nom: H-RRRFRPASPLRGPPK-OH

Description

Peptide H-RRRFRPASPLRGPPK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-RRRFRPASPLRGPPK-OH include the following: The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site YL Woods, G Rena , N Morrice, A Barthel - Biochemical , 2001 - portlandpress.comhttps://portlandpress.com/biochemj/article-abstract/355/3/597/39391 High Throughput Screens Yield Small Molecule Inhibitors of Leishmania CRK3:CYC6 Cyclin-Dependent Kinase RG Walker, G Thomson, K Malone - PLoS neglected , 2011 - journals.plos.orghttps://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0001033 High Throughput Screens Yield Small Molecule Inhibitors of Leishmania RG Walker , G Thomson, K Malone , MW Nowicki - 2011 - academia.eduhttps://www.academia.edu/download/73223248/6ae5e4d00cf4a94c37684f1af050920e1073.pdf Silmitasertib (CX-4945), a clinically used CK2-kinase inhibitor with additional effects on GSK3beta and DYRK1A kinases: A structural perspective P Grygier, K Pustelny, J Nowak, P Golik - Journal of medicinal , 2023 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.2c01887 The structure of a dual-specificity tyrosine phosphorylation-regulated kinase 1A-PKC412 complex reveals disulfide-bridge formation with the anomalous catalytic loop M Alexeeva, E aca
berg, RA Engh - Section D: Biological , 2015 - scripts.iucr.orghttps://scripts.iucr.org/cgi-bin/paper?dw5134 Biophysical characterization of the DYRK family. Studies on the kinases DYRK1A and DYRK1B M Alexeeva - 2013 - munin.uit.nohttps://munin.uit.no/handle/10037/6825 Comparison of cancer cell survival triggered by microtubule damage after turning Dyrk1B kinase on and off L Li , Y Liu, Q Zhang, H Zhou, Y Zhang - ACS Chemical , 2014 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/cb4005589 Benzobisthiazoles represent a novel scaffold for kinase inhibitors of CLK family members K Prak, J Kriston-Vizi , AWE Chan , C Luft, JR Costa - Biochemistry, 2016 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.biochem.5b01128 Urolithin as a converging scaffold linking ellagic acid and coumarin analogues: design of potent protein kinase CK2 inhibitors G Cozza , A Gianoncelli , P Bonvini, E Zorzi - , 2011 - Wiley Online Libraryhttps://chemistry-europe.onlinelibrary.wiley.com/doi/abs/10.1002/cmdc.201100338 Splice variants of the dual specificity tyrosine phosphorylation-regulated kinase 4 (DYRK4) differ in their subcellular localization and catalytic activity C Papadopoulos, K Arato, E Lilienthal - Journal of biological , 2011 - ASBMBhttps://www.jbc.org/article/S0021-9258(20)52120-0/abstract Inhibitors of dual-specificity tyrosine phosphorylation-regulated kinases (DYRK) exert a strong anti-herpesviral activity C Hutterer, J Milbradt, S Hamilton, M Zaja, J Leban - Antiviral research, 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0166354216307847 Diabetic kinome inhibitors-A new opportunity for beta-cells restoration B Pucelik , A Barzowska , JM DÄ browski - International Journal of , 2021 - mdpi.comhttps://www.mdpi.com/1422-0067/22/16/9083 Novel scaffolds for Dual specificity tyrosine-phosphorylation-regulated kinase (DYRK1A) inhibitors A Czarna , J Wang, D Zelencova, Y Liu - Journal of medicinal , 2018 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.7b01847 Academic Editor: Jean Sacaˆbastien Annicotte Received: 6August 2021 Accepted: 26 August 2021 Published: 31 August 2021 Publisheraca­s Note: MDPI stays A Czarna - ruj.uj.edu.plhttps://ruj.uj.edu.pl/bitstreams/19da3af3-77cd-4028-986b-f17e34e28bf1/download DYRK1A Kinase inhibitors promote beta-cell survival and insulin homeostasis A Barzowska , B Pucelik , K Pustelny, A Matsuda - Cells, 2021 - mdpi.comhttps://www.mdpi.com/2073-4409/10/9/2263 DYRK1A Kinase Inhibitors Promote beta-Cell Survival and Insulin Homeostasis. Cells 2021, 10, 2263 A Barzowska , B Pucelik , K Pustelny, A Matsuda - 2021 - pdfs.semanticscholar.orghttps://pdfs.semanticscholar.org/8a9e/c07ba9d70d0487381725124bd9bae7b32a8a.pdf

• Marque: Biosynth